Search

everythinglearnresearchcommunity

for

Search:↓

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Early treatment of Folliculitis Decalvans in children can improve inflammation and partially regrow hair.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

Combination therapy may be more effective for difficult-to-treat scalp conditions.

Microinfusion therapy and testosterone use may cause scalp inflammation, requiring early recognition and treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

New treatments for seborrheic dermatitis show promise for difficult cases.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Quercetin effectively treated and prevented hair loss in mice.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The patient improved significantly after treatment, with only one small scar remaining.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Macrophage issues cause chronic wound inflammation, but therapies can help.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Early detection and treatment are crucial to prevent irreversible hair loss in Lichen Planopilaris.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Combining surgery and photodynamic therapy effectively treated a rare scalp condition when other treatments failed.